
OTCMKTS:NSRGY
This summary was created by AI, based on 3 opinions in the last 12 months.
The reviews regarding Nestlé indicate a cautious outlook for the stock, with concerns raised about its market positioning amidst changing consumer preferences. Experts highlight that the brand is facing challenges due to the rising popularity of weight-loss drugs and a growing shift away from ultra-processed foods. This shift has created a difficult environment for the consumer goods sector, leading to expectations of declining revenues and a potential adjustment in the price-to-earnings (PE) multiple for Nestlé. Furthermore, analysts noted that Nestlé’s designation as a Defensive Equity Operation (DEO) might not be favorable in the current market, suggesting alternative investments in similar sectors. Overall, the sentiment reflects apprehension about Nestlé’s future performance amid broader industry struggles.
This is a global large cap based in the safe haven of Switzerland. It gradually grows its dividend. Has a very good mix of developed and emerging markets. More recently they have been trying to cut costs out of their working capital, and as they bring that cost down, that should start to show up in higher dividends.
This is a massive company. Fairly recently, the new CFO has adopted a strategy where he is going to try to manage down the cash that is involved in working capital. This company is going to continue chugging along. Buy it on a dip if you can. Anyone can put this in their portfolio and if they have a long enough time frame, they’ll make money on it. Best-of-breed company.
This has more sales than some companies have GDP. A massive, massive company. Dividend is very safe. Recently the company changed management and are looking now to streamline their working capital. His understanding is that this will ultimately lead to Return of Capital which will be used in forms of increasing dividends, buybacks, etc. With a longer view timeframe, you won’t be disappointed.
(Swiss exchange) Fantastic company. Had a phenomenal run in growth in the last couple of years. This growth has been largely driven by new product introductions and, obviously, through some of emerging-market growth. For a company this size, it is very difficult to be a high growth story, so if you are looking for high growth, this is not for you. He prefers Unilever (UL-N). Danone (BN-FP) is the one that is on sale. The other 2 are expensive.
Had a pretty decent run over the last little while. Pretty good defensive company. Likes the mix of revenues that come from emerging markets. Given the run-up it has had, he would recommend watching it and trying to get it a little cheaper or put only 50% in and add to it when the opportunity arises.
Well run and diversified company. They don’t have a lot of manufacturing in Switzerland for export. Last week their short debt was trading at a negative yield. It is going to get more expensive.